WCA
RXDX
Waypoint Capital Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-154,466
| Closed | -$16.6M | – | 135 |
|
|
2023
Q1 | $16.6M | Sell |
154,466
-16,715
| -10% | -$1.79M | 5.4% | 2 |
|
|
2022
Q4 | $18.8M | Sell |
171,181
-21,894
| -11% | -$2.41M | 6.53% | 2 |
|
|
2022
Q3 | $11.4M | Buy |
193,075
+40,410
| +26% | +$2.38M | 4.97% | 2 |
|
|
2022
Q2 | $4.31M | Sell |
152,665
-83,091
| -35% | -$2.35M | 1.96% | 16 |
|
|
2022
Q1 | $8.73M | Buy |
235,756
+83,091
| +54% | +$3.08M | 5.13% | 4 |
|
|
2021
Q4 | $6.04M | Buy |
+152,665
| New | +$6.04M | 4.14% | 6 |
|